Vertex Pharma Q3 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript November 6, 2023
Ocean Biomedical forms JV with Virion Therapeutics to find treatments for cancer and chronic infectious diseases October 12, 2023
Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations October 3, 2023
Ocean Biomedical provides update on programs in malaria, fibrosis, and multiple cancers August 10, 2023
Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights August 9, 2023
Ocean Biomedical’s share price target averages $18.21 amid continued progress in research programs August 9, 2023
Ocean Biomedical shares details of its successful lung cancer program on World Lung Cancer Day August 1, 2023
